Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of atractylenolide II for preparing medicine capable of improving insulin resistance and glucose-lipid metabolism disorder caused by obesity

A technique of atractylide and its use, applied in the field of medicine, can solve the problems that have not yet been seen.

Inactive Publication Date: 2019-12-10
CHINA PHARM UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no application of Atractylolide II to improve insulin resistance and glucose and lipid metabolism disorders caused by obesity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of atractylenolide II for preparing medicine capable of improving insulin resistance and glucose-lipid metabolism disorder caused by obesity
  • Application of atractylenolide II for preparing medicine capable of improving insulin resistance and glucose-lipid metabolism disorder caused by obesity
  • Application of atractylenolide II for preparing medicine capable of improving insulin resistance and glucose-lipid metabolism disorder caused by obesity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The following describes the substantive content of the present invention in detail in conjunction with the drawings and embodiments, but does not limit the protection scope of the present invention.

[0025] 1. Reagents and materials

[0026] C57BL / 6J mice, 6-7 weeks old, male, SPF grade. Purchased from SPEF (Beijing) Biotechnology Co., Ltd. (licence: SCXK (Beijing) 2016-0002), quality inspection unit: Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. testing room, animal experiment unit: China Pharmaceutical University , NO.1103241911003587, experimental unit license number: SYXK (Su) 2016-0011.

[0027] Atractylenolide II (2-Atractylenolide) was purchased from Chengdu Master Biotechnology Co., Ltd., product number: A0373-3g, batch number: MUST-19030202, CAS NO: 73069-14-4, MF: C15H20O2, MW: 232.32Purity : 99.99% (HPLC).

[0028] Metformin (Metformin Hydrochloride) was purchased from MedChemExpress, product number: HY-17471A / CS-1851, CAS NO: 1115-70-4, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of atractylenolide II for preparing a medicine capable of improving insulin resistance and glucose-lipid metabolism disorder caused by obesity. After mice are fed in a high fat mode, the weights of the mice are increased, and respiratory quotient and energy consumption are obviously reduced, and thus, fat mice mainly take lipid metabolism as a main part insteadof glucose metabolism as the main part, fat tissues are pathologically changed and lipid droplets are increased, and meanwhile, some index detection of blood plasma and liver also proves diseases of liver damage and insulin resistance of the mice. Based on the application of the atractylenolide II disclosed by the invention, after the atractylenolide II is provided for treatment, the weights and the glucose-lipid metabolism of the fat mice are improved, the lipid droplets of the livers are reduced, and the insulin resistance is recovered. Therefore, because of the atractylenolide II, the insulin resistance and the glucose-lipid metabolism disorder caused by the obesity can be effectively improved.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to the new application of known compounds, in particular to the application of atractyloid II for the preparation of medicines for improving insulin resistance and glucose and lipid metabolism disorders caused by obesity. Background technique [0002] Obesity is caused by excessive energy intake, which significantly exceeds energy consumption, resulting in lipid metabolism disorder. Lipid disorder can reduce insulin sensitivity and cause insulin resistance. In the pathological process of obesity-induced insulin resistance, high expression of lipase (LPL) was found in the liver of liver-specific insulin-resistant lipid accumulation mice. In recent years, studies have shown that diacylglycerols (DAGs) or ceramides ( Ceramides) are the material basis of insulin resistance. In an obese type II prediabetic model, mainly liver tissue DAGs mediate the insulin resistance induced by lipid accumulation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/365A61P5/50A61P3/00A61P1/16
CPCA61K31/365A61P5/50A61P3/00A61P1/16
Inventor 李萍杨华郑祖国徐殷越张晓雨
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com